search
Back to results

Functional Imaging of Social Cognition in Premanifest Huntington's Disease (FISCIP)

Primary Purpose

Huntington's Disease

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
functional Imaging
Sponsored by
Universitaire Ziekenhuizen KU Leuven
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Huntington's Disease

Eligibility Criteria

18 Years - 90 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Huntington's disease positive genotype and non-carrier siblings

Exclusion Criteria:

  • visible chorea
  • MRI contra-indications
  • major neurological/psychiatric comorbidity

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    functional Imaging mutation carrier

    functional Imaging non-carrier

    Arm Description

    Premanifest mutation carrier, behavioral and neural emotional memory processing

    non-carrier family member, behavioral and neural emotional memory processing

    Outcomes

    Primary Outcome Measures

    Significant group differences in brain activation for perceiving emotional vs neutral faces by following random effects analyses
    Significant group differences in beta-values for the contrast emotional faces vs neutral faces following general linear model parameter estimates

    Secondary Outcome Measures

    Full Information

    First Posted
    September 7, 2015
    Last Updated
    September 14, 2015
    Sponsor
    Universitaire Ziekenhuizen KU Leuven
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02551705
    Brief Title
    Functional Imaging of Social Cognition in Premanifest Huntington's Disease
    Acronym
    FISCIP
    Official Title
    Functional Imaging of Social Cognition in Premanifest Huntington's Disease
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    September 2015
    Overall Recruitment Status
    Unknown status
    Study Start Date
    October 2015 (undefined)
    Primary Completion Date
    October 2017 (Anticipated)
    Study Completion Date
    October 2017 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Universitaire Ziekenhuizen KU Leuven

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Huntington's disease (HD) is a genetic progressive fatal neurodegenerative disorder. In the western world it affects 5-10 persons per 100000. The main brain changes include the loss of brain cells in subcortical structures. The symptoms of HD include involuntary movements, cognitive deterioration and behavioural disturbances. It has been shown that changes in emotion comprehension occur before the onset of the motor symptoms (preHD). This deficit in perception of emotions has been primarily investigated by means of facial expressions. However, emotions can also be expressed through body language. Here, the investigators propose to investigate whether the emotion comprehension deficit in preHD also includes body language comprehension.
    Detailed Description
    The investigators will perform a detailed evaluation of body language comprehension abilities in persons that carry the genetic mutation causing HD, but who do not show any movement symptoms yet. In addition, the associated changes in brain structure and function will be studied. The aim is to perform the study with the same group of participants who participated in a recent study carried on by this research group, in which the functional brain changes associated with increased irritability were investigated. This will allow to relate emotion experience with emotion perception. The results of the study may provide a target to further develop therapeutic interventions and aid caregivers of preHD subjects.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Huntington's Disease

    7. Study Design

    Primary Purpose
    Basic Science
    Study Phase
    Not Applicable
    Interventional Study Model
    Crossover Assignment
    Masking
    Investigator
    Allocation
    Non-Randomized
    Enrollment
    40 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    functional Imaging mutation carrier
    Arm Type
    Experimental
    Arm Description
    Premanifest mutation carrier, behavioral and neural emotional memory processing
    Arm Title
    functional Imaging non-carrier
    Arm Type
    Active Comparator
    Arm Description
    non-carrier family member, behavioral and neural emotional memory processing
    Intervention Type
    Other
    Intervention Name(s)
    functional Imaging
    Intervention Description
    Brain responses associated with emotional memory will be investigated
    Primary Outcome Measure Information:
    Title
    Significant group differences in brain activation for perceiving emotional vs neutral faces by following random effects analyses
    Description
    Significant group differences in beta-values for the contrast emotional faces vs neutral faces following general linear model parameter estimates
    Time Frame
    6 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    90 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Huntington's disease positive genotype and non-carrier siblings Exclusion Criteria: visible chorea MRI contra-indications major neurological/psychiatric comorbidity

    12. IPD Sharing Statement

    Learn more about this trial

    Functional Imaging of Social Cognition in Premanifest Huntington's Disease

    We'll reach out to this number within 24 hrs